VSY Biotechnology Corporate Video

Vizionat 1,597 ori
8.0
Îți mulțumim, votul tău a fost înregistrat și va apărea în curând.
Da
Nu
Adăugat la profilul tău elementele marcate.

Descrierea videoclipului:

Despre ce este VSY Biotechnology Corporate Video?

All our products go through rigorous and comprehensive research and development to ensure manufacturing efficiency and the highest optic quality. With our superior product line and our sterling focus on our customers needs, we at VSY Biotechnology believe that the future could not be clearer.
VSY Biotechnology focuses on cataract products and developing improvements to existing intraocular lens models. We deliver our technologies through two complementary product lines, each providing specific solutions to address ophthalmologist's and patients' needs.
Thanks to its advanced technology, VSY Biotechnology presents monofocal and multifocal IOLs in different platforms (Modified C, Balance and Plate Haptic). Beside those products the company has foldable scleral fixation lens.
Beside intraocular lenses VSY Biotechnology also manufactures viscoelastics and injector and cardridge systems for cataract surgery.
Customer satisfaction and trust are the foundation of VSY Biotechnology. We believe that our customers come first. We manufacture and produce innovative ophthalmology products and brands that are at the forefront of the world wide global market in pursuit of total customer satisfaction.

Putem juca VSY Biotechnology Corporate Video pe telefonul mobil?

Nu, VSY Biotechnology Corporate Video este creat pentru jucatul pe desktop și funcționează cel mai bine pe calculatoare folosind o tastatură sau un mouse.

Este VSY Biotechnology Corporate Video gratuit de jucat?

Da, VSY Biotechnology Corporate Video este gratuit de jucat pe Y8 și funcționează direct din browserul tău?

Putem juca VSY Biotechnology Corporate Video în modul de monitor complet?

Da, VSY Biotechnology Corporate Video poate fi jucat în mod de ecran complet pentru o experiență mai profundă.
Adăugat la: 25 Apr 2017
Comentarii